In Canada, vaccination pressure continues to grow. The result is shocking: cases of myocarditis are exploding among adolescents. But the health authorities are declining.
Anyone who lives in Canada or has relatives or acquaintances there knows that the vaccination pressure is enormous in the North American country. This pressure is also being passed on to the youth in the country. But this has its price.
As the Ontario health authority numbers (Reference to the PDF) clarify, the risk of myocarditis in the age group of 12-17 year old male adolescents almost doubled within just two months. The following tweet shows this very clearly:
It can be assumed that these numbers are representative for the whole of Canada, especially since Ontario is the country’s most populous province.
Dangerous mRNA vaccines?
In one official Canadian report it says in general and without any age information:
There have been a relatively small number of reports of myocarditis and / or pericarditis following COVID-19 vaccination in Canada. As of September 24, 2021, 812 cases of myocarditis and / or pericarditis were reported to the Public Health Agency of Canada (PHAC) and Health Canada due to over 56 million COVID-19 vaccine doses administered. Of the 812 myocarditis and / or pericarditis cases:
– 466 cases received the COVID-19 vaccine from Pfizer-BioNTech
– 321 cases received the Moderna vaccine
– 21 cases received COVISHIELD / AstraZeneca vaccines
– in four cases the name of the vaccine was not given
But the Canadian authorities continue to insist that the youth be vaccinated. This would significantly reduce the risks of Covid disease (although the hospitalization rates are extremely low among adolescents).
And not only that: in Canada too, vaccination of young people against Covid-19 is only just beginning. How many cases of serious vaccine damage and death must there still be?
Yet despite all the risks, many parents continue to insist on giving their children this mRNA gene therapy.
Hardly any adolescents among the Covid hospitalizations
Although the numbers speak for themselves, the Canadian authorities want to further increase the vaccination rate among adolescents. It is currently around 70 percent.
In one Document writes the Canadian government:
Since the beginning of the COVID-19 pandemic, the COVID-19 rate in Canadian teenagers has been similar to that of young adults. Adolescents are generally mildly ill and report less severe consequences of COVID-19 (i.e., hospitalizations associated with COVID-19, ICU admissions, and deaths) compared to older age groups. Teenagers ages 12-17 make up about 8% of the population, and this age group makes up about 7% of the COVID-19 cases reported nationwide. In contrast, adolescents aged 12 to 17 make up about 0.6% of COVID-19 cases that result in hospitalization, about 0.4% of COVID-19 cases treated in intensive care and about 0.01% of cases leading to death (January 1, 2020 to August 13, 2021).
Since May 2021 (at the same time as the increasing importance of the Delta-Variant B.1.617.2 and the decreasing number of hospitalizations in adults) has increased the relative disease burden in adolescents aged 12 to 17 years, about 8% of COVID-19 cases, 1.2% of COVID-19 cases leading to hospitalization, 0.8% of COVID-19 cases leading to ICU treatment, and 0.08% of deaths increased.
Obviously, the higher vaccination coverage does not protect against a slight increase in the hospitalization rate among young people, while at the same time the risk due to the vaccine side effects increases significantly.